Optimization of the First Step of Enoxaparin Synthesis by Hydrolytic Depolymerization of Unfractionated Heparin


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

The first step of low-molecular-mass heparin (enoxaparin) preparation by hydrolytic depolymerization of unfractionated heparin was investigated. The step involved chemical reaction of starting heparin and benzethonium chloride in aqueous saline solutions. The number of acid equivalents in unfractionated heparin was shown to increase as the NaCl concentration increased. This was probably related to effects of the solution ionic strength on the heparin macromolecular conformation, which was confirmed using dynamic light scattering. The average size of the observed light-scattering centers in aqueous heparin solutions decreased with increasing NaCl concentration. Rinsing with H2O and not NaCl solutions and application of ultrasonication were recommended to accelerate purification of benzethonium heparinate from starting materials and to reduce the amount of rinse water. The compositions of the produced and purified benzethonium heparinate samples were confirmed using PMR spectroscopy.

Об авторах

L. Frumin

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Автор, ответственный за переписку.
Email: leflab39@mail.ru
Россия, Moscow, 119571

K. Yur’eva

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Россия, Moscow, 119571

A. Askretkov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Россия, Moscow, 119571

D. Prokhorov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Россия, Moscow, 119571

A. Matveev

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Россия, Moscow, 119571

E. Zhavoronok

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Россия, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Россия, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

D. Shatalov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Россия, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

E. Shnyak

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Россия, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

S. Kedik

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Россия, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).